StonvexLoading…
StonvexStonvexStonvexCore line items from NCNO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $594.78M | $540.66M | $476.54M | $408.31M |
Operating Income | $3.73M | $-18.13M | $-39.51M | $-94.01M |
Net Income | $5.18M | $-37.88M | $-42.35M | $-102.72M |
EPS (Diluted) | $0.05 | $-0.33 | $-0.38 | $-0.93 |
Total Assets | $1.65B | $1.61B | $1.34B | $1.33B |
Total Liabilities | $579.45M | $512.78M | $287.83M | $299.60M |
Cash & Equivalents | $88.37M | $120.93M | $112.08M | $82.04M |
Free Cash Flow OCF − CapEx | $82.56M | $53.38M | $53.77M | $-33.72M |
Shares Outstanding | 113.90M | 116.00M | 113.68M | 111.42M |